Based on the comparatively unique presentation of hidradenitis suppurativa (HS) and its known psychological impacts, an international team has developed a HS-specific quality of life (QoL) measure. Part of the rationale for developing this measure is that research into development of new treatments of HS will require measures of improvement that address patient-reported outcomes, rather than just clinical outcomes, senior author Dr. Jerry Tan told DERM.city. The typical locat